Advanced sequence optimization for the high efficient yield of human group A rotavirus VP6 recombinant protein in Escherichia coli and its use as immunogen

J Med Virol. 2021 Jun;93(6):3549-3556. doi: 10.1002/jmv.26522. Epub 2020 Oct 5.

Abstract

Rotavirus is the important etiological agents of infectious diarrhea among children under 5 years old. Rotaviruses are divided into 10 serogroups (A-J) and each group is based on genetic properties of major structural protein VP6. We designed a novel VP6 sequence optimization to increase the expression level of this protein. Numerous factors such as codon adaptation index, codon pair bias, and guanine-cytosine content were adapted based on Escherichiacoli codon usage. In addition, the ribosome binding site (RBS) of pET-15b was redesigned by the RBS calculator and the secondary structure of VP6 messenger RNA was optimized in the whole length of the coding sequence. Various factors including isopropyl beta- d-thiogalactoside (IPTG) concentration, temperature, and induction time were analyzed for the optimization of the best expression in E. coli by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blotting. The recombinant VP6 (rVP6) protein was purified by the Ni-sepharose and then the hyperimmune sera were generated against rVP6 in rabbits. Among three different temperatures, IPTG concentrations, and postinductions, the level of rVP6 was higher at 37°C, 1 mM of IPTG, and 8 h, respectively. Also, the high expression level of rVP6 was obtained in the insoluble aggregate form (43.8 g/L). After purification, the yield of rVP6 was 10.83 g/L. The rVP6 specific antiserum was confirmed by both immunofluorescent and western blotting. The versatile sequence optimization was the reason to produce a high level of rVP6 compared to other reports and can potentially apply to produce cheaper commercial kits to diagnose serological tests and new rotavirus vaccines.

Keywords: antiserum; commercial kit; recombinant VP6; rotavirus; sequence optimization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Antigens, Viral / genetics*
  • Antigens, Viral / immunology*
  • Antigens, Viral / isolation & purification
  • Capsid Proteins / genetics*
  • Capsid Proteins / immunology*
  • Capsid Proteins / isolation & purification
  • Codon / genetics
  • Codon / immunology
  • Escherichia coli / genetics*
  • Female
  • Humans
  • Immunization / methods
  • Immunization, Secondary
  • Rabbits
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Recombinant Proteins / isolation & purification
  • Rotavirus / chemistry
  • Rotavirus / genetics*
  • Rotavirus / immunology*
  • Rotavirus Infections / immunology
  • Rotavirus Infections / prevention & control
  • Rotavirus Vaccines / administration & dosage
  • Rotavirus Vaccines / immunology*
  • Vaccines, Synthetic / administration & dosage

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Capsid Proteins
  • Codon
  • Recombinant Proteins
  • Rotavirus Vaccines
  • VP6 protein, Rotavirus
  • Vaccines, Synthetic